Previous studies reported a reactivation of the proapoptotic factor Bid [6], or a change in the balance of pro- and antiapoptotic Bcl-2 family members to account for increased apoptosis rates following inactivation of HIF-1α in drug-treated gastric cancer cells [18]. Here, BCL2 is linked to gastric cancer.